The UK Medicines and Healthcare products Regulatory Agency (MHRA) has announced a new Community of Practice for Digital Mental Health Technologies, in an announcement published on the regulator's official blog.
The agency describes the move as an effort to strengthen regulatory understanding, shared learning and practical support for developers working in one of the fastest-growing areas of UK medtech. The stated aim is to help innovators navigate regulatory expectations, improve compliance and accelerate safe, effective digital mental health solutions into clinical use.
The initiative responds to what the MHRA presents as growing demand for clarity on evidence requirements, post-market responsibilities and an evolving regulatory landscape for software-based and AI-enabled mental health tools. That category stretches from therapeutic apps to AI-supported assessment tools.
A forum spanning the sector
The community is intended to bring together developers, clinicians, researchers, commissioners and regulatory specialists to build a shared understanding of best practice. For the wider medtech development community, the agency frames it as an opportunity to engage directly with the regulator on questions that often determine whether a promising technology reaches patients.
Stated objectives
- Supporting developers in interpreting regulatory requirements and embedding compliance earlier in product design.
- Identifying common challenges faced by innovators, particularly small and medium-sized enterprises entering the mental health space.
- Sharing real-world experience from organisations already working through regulatory pathways.
- Strengthening dialogue between industry and regulators so that emerging technologies meet safety, performance and evidence expectations.
Survey to shape initial priorities
To set the community's initial priorities, the MHRA has opened a survey seeking input from digital mental health technology developers and other stakeholders across the medtech ecosystem. The survey explores current regulatory challenges, the areas where clearer guidance is needed, and opportunities to improve compliance support.
The agency is encouraging broad participation so that the community reflects real-world needs rather than top-down assumptions. For developers, the survey is presented as a direct route to influence future regulatory support and to help shape a more predictable, transparent environment for innovation.
Developers are urged to complete the survey and to share it within their organisations; according to the announcement, a strong response will help ensure the new community delivers practical, meaningful support.
The announcement as published does not set out a timetable for the community's first meetings, a membership process, or how the survey findings will be reported.